Microglia in human immunodeficiency virus-associated neurodegeneration

Area of Science:

• Neuroscience
• Immunology
• Virology

Background:

• Human immunodeficiency virus (HIV) infection is linked to neurological disorders, including HIV-associated dementia (HAD).
• Neurons are not directly infected by HIV, suggesting indirect mechanisms for neurodegeneration.
• Microglia, the primary HIV-infected cells in the central nervous system (CNS), are implicated in HAD pathogenesis.

Purpose of the Study:

• To review the pathophysiology of HIV-associated dementia (HAD).
• To explore the role of microglia in HIV-induced neurotoxicity.
• To identify molecular mediators of neuronal injury and potential therapeutic strategies.

Main Methods:

• Review of clinical and pathological studies.
• Analysis of animal models of HAD.
• Examination of in vitro models of microglial activation and neurotoxicity.

Main Results:

• Microglial infection and activation are central to neurological dysfunction in HAD.
• Activated microglia release neurotoxic factors that damage neurons and synapses.
• Evidence supports microglial dysfunction as the initiating event in a cascade of neuronal injury.

Conclusions:

• Altered microglial function drives neuronal damage in HAD.
• Identification of microglial-derived neurotoxins offers therapeutic targets.
• Interventions aimed at modulating microglial activity may mitigate HAD progression.